Follow the NGL Fine-Chem Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, NGL Fine-Chem Limited has logged 16 insider filings. Market capitalisation: €17.2bn. The latest transaction was filed on 16 September 2023 (Sale). Among the most active insiders: SUNITA POTDAR. The full history is openly available.
16
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€955,425
16 ops.
Sell Volume
4Σ signal
Buys ·€955,425 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,388 of 26,213 companies
51.3
score / 100
Value
32
Quality
71
FCF yld-2.4%
Earn yld2.4%
EV/EBITDA23.8x
ROE16%
Gross mgn52%
Net mgn9.6%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.